Caris Life Sciences, Inc.
Caris Life Sciences, Inc. (CAI) Stock Competitors & Peer Comparison
See (CAI) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CAI | $36.99 | +0.00% | 10.3B | -9.24 | -$3.95 | N/A |
| URI | $921.45 | +0.00% | 58.5B | 23.56 | $38.59 | +0.77% |
| AER | $112.74 | +0.00% | 20B | 7.07 | $16.00 | +0.94% |
| CTOS-WT | $0.11 | -7.93% | 18B | N/A | N/A | N/A |
| FTAI | $144.90 | +0.00% | 14.8B | 35.56 | $4.07 | +0.83% |
| UHAL-B | $53.53 | +0.00% | 10.4B | 37.37 | $1.42 | N/A |
| UHAL | $58.29 | +0.00% | 10B | 40.67 | $1.42 | N/A |
| R | $182.11 | +0.00% | 7.3B | 15.30 | $11.76 | +1.81% |
| AL | $57.91 | +0.00% | 6.4B | 6.95 | $8.24 | +1.52% |
| AL-PA | $35.02 | -0.61% | 5.9B | -26.35 | -$1.33 | +1.52% |
Stock Comparison
CAI vs URI Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, URI has a market cap of 58.5B. Regarding current trading prices, CAI is priced at $36.99, while URI trades at $921.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas URI's P/E ratio is 23.56. In terms of profitability, CAI's ROE is +0.04%, compared to URI's ROE of +0.29%. Regarding short-term risk, CAI is more volatile compared to URI. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check URI's competition here
CAI vs AER Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, AER has a market cap of 20B. Regarding current trading prices, CAI is priced at $36.99, while AER trades at $112.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas AER's P/E ratio is 7.07. In terms of profitability, CAI's ROE is +0.04%, compared to AER's ROE of +0.17%. Regarding short-term risk, CAI is more volatile compared to AER. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AER's competition here
CAI vs CTOS-WT Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, CTOS-WT has a market cap of 18B. Regarding current trading prices, CAI is priced at $36.99, while CTOS-WT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas CTOS-WT's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to CTOS-WT's ROE of -0.02%. Regarding short-term risk, CAI is more volatile compared to CTOS-WT. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check CTOS-WT's competition here
CAI vs FTAI Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAI has a market cap of 14.8B. Regarding current trading prices, CAI is priced at $36.99, while FTAI trades at $144.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAI's P/E ratio is 35.56. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAI. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI's competition here
CAI vs UHAL-B Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, UHAL-B has a market cap of 10.4B. Regarding current trading prices, CAI is priced at $36.99, while UHAL-B trades at $53.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas UHAL-B's P/E ratio is 37.37. In terms of profitability, CAI's ROE is +0.04%, compared to UHAL-B's ROE of +0.04%. Regarding short-term risk, CAI is more volatile compared to UHAL-B. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check UHAL-B's competition here
CAI vs UHAL Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, UHAL has a market cap of 10B. Regarding current trading prices, CAI is priced at $36.99, while UHAL trades at $58.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas UHAL's P/E ratio is 40.67. In terms of profitability, CAI's ROE is +0.04%, compared to UHAL's ROE of +0.04%. Regarding short-term risk, CAI is more volatile compared to UHAL. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check UHAL's competition here
CAI vs R Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, R has a market cap of 7.3B. Regarding current trading prices, CAI is priced at $36.99, while R trades at $182.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas R's P/E ratio is 15.30. In terms of profitability, CAI's ROE is +0.04%, compared to R's ROE of +0.17%. Regarding short-term risk, CAI is more volatile compared to R. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check R's competition here
CAI vs AL Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, AL has a market cap of 6.4B. Regarding current trading prices, CAI is priced at $36.99, while AL trades at $57.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas AL's P/E ratio is 6.95. In terms of profitability, CAI's ROE is +0.04%, compared to AL's ROE of +0.12%. Regarding short-term risk, CAI is more volatile compared to AL. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AL's competition here
CAI vs AL-PA Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, AL-PA has a market cap of 5.9B. Regarding current trading prices, CAI is priced at $36.99, while AL-PA trades at $35.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas AL-PA's P/E ratio is -26.35. In terms of profitability, CAI's ROE is +0.04%, compared to AL-PA's ROE of +0.12%. Regarding short-term risk, CAI is more volatile compared to AL-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AL-PA's competition here
CAI vs PONY Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, PONY has a market cap of 5.6B. Regarding current trading prices, CAI is priced at $36.99, while PONY trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas PONY's P/E ratio is -17.62. In terms of profitability, CAI's ROE is +0.04%, compared to PONY's ROE of -0.42%. Regarding short-term risk, CAI is more volatile compared to PONY. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check PONY's competition here
CAI vs GATX Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, GATX has a market cap of 5.6B. Regarding current trading prices, CAI is priced at $36.99, while GATX trades at $157.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas GATX's P/E ratio is 17.90. In terms of profitability, CAI's ROE is +0.04%, compared to GATX's ROE of +0.13%. Regarding short-term risk, CAI is more volatile compared to GATX. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check GATX's competition here
CAI vs CAR Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, CAR has a market cap of 5.5B. Regarding current trading prices, CAI is priced at $36.99, while CAR trades at $158.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas CAR's P/E ratio is -2.48. In terms of profitability, CAI's ROE is +0.04%, compared to CAR's ROE of +1.09%. Regarding short-term risk, CAI is more volatile compared to CAR. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check CAR's competition here
CAI vs WSC Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, WSC has a market cap of 4.4B. Regarding current trading prices, CAI is priced at $36.99, while WSC trades at $24.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas WSC's P/E ratio is 40.98. In terms of profitability, CAI's ROE is +0.04%, compared to WSC's ROE of +0.11%. Regarding short-term risk, CAI is more volatile compared to WSC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check WSC's competition here
CAI vs TRTN Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN has a market cap of 4.4B. Regarding current trading prices, CAI is priced at $36.99, while TRTN trades at $79.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN's P/E ratio is 7.74. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN's competition here
CAI vs HRI Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, HRI has a market cap of 4.1B. Regarding current trading prices, CAI is priced at $36.99, while HRI trades at $125.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas HRI's P/E ratio is 150.37. In terms of profitability, CAI's ROE is +0.04%, compared to HRI's ROE of +0.01%. Regarding short-term risk, CAI is more volatile compared to HRI. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HRI's competition here
CAI vs HEES Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, HEES has a market cap of 3.5B. Regarding current trading prices, CAI is priced at $36.99, while HEES trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas HEES's P/E ratio is 38.01. In terms of profitability, CAI's ROE is +0.04%, compared to HEES's ROE of +0.14%. Regarding short-term risk, CAI is more volatile compared to HEES. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HEES's competition here
CAI vs MGRC Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, MGRC has a market cap of 2.9B. Regarding current trading prices, CAI is priced at $36.99, while MGRC trades at $119.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas MGRC's P/E ratio is 11.65. In terms of profitability, CAI's ROE is +0.04%, compared to MGRC's ROE of +0.22%. Regarding short-term risk, CAI is more volatile compared to MGRC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check MGRC's competition here
CAI vs FTAIM Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAIM has a market cap of 2.7B. Regarding current trading prices, CAI is priced at $36.99, while FTAIM trades at $26.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAIM's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIM's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAIM. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIM's competition here
CAI vs TRTN-PA Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN-PA has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $36.99, while TRTN-PA trades at $25.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN-PA's P/E ratio is 3.25. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PA's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PA's competition here
CAI vs FTAIO Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAIO has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $36.99, while FTAIO trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAIO's P/E ratio is -7.34. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIO's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAIO. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIO's competition here
CAI vs FTAIN Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAIN has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $36.99, while FTAIN trades at $25.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAIN's P/E ratio is -7.28. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIN's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAIN. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIN's competition here
CAI vs TRTN-PB Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN-PB has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $36.99, while TRTN-PB trades at $25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN-PB's P/E ratio is 3.17. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PB's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PB's competition here
CAI vs FTAIP Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAIP has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $36.99, while FTAIP trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAIP's P/E ratio is -7.32. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIP's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAIP. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIP's competition here
CAI vs TRTN-PC Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN-PC has a market cap of 2.5B. Regarding current trading prices, CAI is priced at $36.99, while TRTN-PC trades at $25.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN-PC's P/E ratio is 3.10. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PC's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PC's competition here
CAI vs TRTN-PD Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN-PD has a market cap of 2.4B. Regarding current trading prices, CAI is priced at $36.99, while TRTN-PD trades at $23.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN-PD's P/E ratio is 2.90. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PD's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PD. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PD's competition here
CAI vs TGH Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TGH has a market cap of 2.1B. Regarding current trading prices, CAI is priced at $36.99, while TGH trades at $49.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TGH's P/E ratio is 11.55. In terms of profitability, CAI's ROE is +0.04%, compared to TGH's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH's competition here
CAI vs TRTN-PE Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TRTN-PE has a market cap of 2B. Regarding current trading prices, CAI is priced at $36.99, while TRTN-PE trades at $20.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TRTN-PE's P/E ratio is 2.50. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PE's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PE. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PE's competition here
CAI vs HTZ Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, HTZ has a market cap of 1.6B. Regarding current trading prices, CAI is priced at $36.99, while HTZ trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas HTZ's P/E ratio is -0.62. In terms of profitability, CAI's ROE is +0.04%, compared to HTZ's ROE of -149.88%. Regarding short-term risk, CAI is more volatile compared to HTZ. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HTZ's competition here
CAI vs RCII Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, RCII has a market cap of 1.5B. Regarding current trading prices, CAI is priced at $36.99, while RCII trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas RCII's P/E ratio is 81.15. In terms of profitability, CAI's ROE is +0.04%, compared to RCII's ROE of +0.23%. Regarding short-term risk, CAI is more volatile compared to RCII. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check RCII's competition here
CAI vs CTOS Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, CTOS has a market cap of 1.3B. Regarding current trading prices, CAI is priced at $36.99, while CTOS trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas CTOS's P/E ratio is -36.75. In terms of profitability, CAI's ROE is +0.04%, compared to CTOS's ROE of -0.02%. Regarding short-term risk, CAI is more volatile compared to CTOS. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check CTOS's competition here
CAI vs PRG Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, PRG has a market cap of 1.3B. Regarding current trading prices, CAI is priced at $36.99, while PRG trades at $33.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas PRG's P/E ratio is 6.60. In terms of profitability, CAI's ROE is +0.04%, compared to PRG's ROE of +0.33%. Regarding short-term risk, CAI is more volatile compared to PRG. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check PRG's competition here
CAI vs WLFC Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, WLFC has a market cap of 1.1B. Regarding current trading prices, CAI is priced at $36.99, while WLFC trades at $162.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas WLFC's P/E ratio is 9.37. In terms of profitability, CAI's ROE is +0.04%, compared to WLFC's ROE of +0.21%. Regarding short-term risk, CAI is more volatile compared to WLFC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check WLFC's competition here
CAI vs TGH-PA Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TGH-PA has a market cap of 1B. Regarding current trading prices, CAI is priced at $36.99, while TGH-PA trades at $25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TGH-PA's P/E ratio is 4.44. In terms of profitability, CAI's ROE is +0.04%, compared to TGH-PA's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH-PA's competition here
CAI vs TGH-PB Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, TGH-PB has a market cap of 1B. Regarding current trading prices, CAI is priced at $36.99, while TGH-PB trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas TGH-PB's P/E ratio is 4.44. In terms of profitability, CAI's ROE is +0.04%, compared to TGH-PB's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH-PB's competition here
CAI vs HTZWW Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, HTZWW has a market cap of 879.6M. Regarding current trading prices, CAI is priced at $36.99, while HTZWW trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas HTZWW's P/E ratio is 2.37. In terms of profitability, CAI's ROE is +0.04%, compared to HTZWW's ROE of -149.88%. Regarding short-term risk, CAI is more volatile compared to HTZWW. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HTZWW's competition here
CAI vs ALTG-PA Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, ALTG-PA has a market cap of 805.7M. Regarding current trading prices, CAI is priced at $36.99, while ALTG-PA trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas ALTG-PA's P/E ratio is -41.21. In terms of profitability, CAI's ROE is +0.04%, compared to ALTG-PA's ROE of -0.96%. Regarding short-term risk, CAI is more volatile compared to ALTG-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check ALTG-PA's competition here
CAI vs VSTS Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, VSTS has a market cap of 617M. Regarding current trading prices, CAI is priced at $36.99, while VSTS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas VSTS's P/E ratio is -20.35. In terms of profitability, CAI's ROE is +0.04%, compared to VSTS's ROE of -0.03%. Regarding short-term risk, CAI is more volatile compared to VSTS. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check VSTS's competition here
CAI vs AAN Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, AAN has a market cap of 318.3M. Regarding current trading prices, CAI is priced at $36.99, while AAN trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas AAN's P/E ratio is -7.26. In terms of profitability, CAI's ROE is +0.04%, compared to AAN's ROE of -0.04%. Regarding short-term risk, CAI is more volatile compared to AAN. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AAN's competition here
CAI vs ALTG Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, ALTG has a market cap of 257.7M. Regarding current trading prices, CAI is priced at $36.99, while ALTG trades at $8.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas ALTG's P/E ratio is -3.88. In terms of profitability, CAI's ROE is +0.04%, compared to ALTG's ROE of -0.96%. Regarding short-term risk, CAI is more volatile compared to ALTG. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check ALTG's competition here
CAI vs MPU Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, MPU has a market cap of 130.7M. Regarding current trading prices, CAI is priced at $36.99, while MPU trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas MPU's P/E ratio is -8.11. In terms of profitability, CAI's ROE is +0.04%, compared to MPU's ROE of -0.71%. Regarding short-term risk, CAI is less volatile compared to MPU. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check MPU's competition here
CAI vs MTMT Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, MTMT has a market cap of 52.4M. Regarding current trading prices, CAI is priced at $36.99, while MTMT trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas MTMT's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to MTMT's ROE of -0.44%. Regarding short-term risk, CAI is more volatile compared to MTMT. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check MTMT's competition here
CAI vs FPAY Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FPAY has a market cap of 12.2M. Regarding current trading prices, CAI is priced at $36.99, while FPAY trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FPAY's P/E ratio is -2.85. In terms of profitability, CAI's ROE is +0.04%, compared to FPAY's ROE of -0.05%. Regarding short-term risk, CAI is less volatile compared to FPAY. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check FPAY's competition here
CAI vs MWG Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, MWG has a market cap of 7.3M. Regarding current trading prices, CAI is priced at $36.99, while MWG trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas MWG's P/E ratio is -2.42. In terms of profitability, CAI's ROE is +0.04%, compared to MWG's ROE of -0.14%. Regarding short-term risk, CAI is more volatile compared to MWG. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check MWG's competition here
CAI vs ZCAR Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, ZCAR has a market cap of 3.1M. Regarding current trading prices, CAI is priced at $36.99, while ZCAR trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas ZCAR's P/E ratio is -0.01. In terms of profitability, CAI's ROE is +0.04%, compared to ZCAR's ROE of +105.44%. Regarding short-term risk, CAI is more volatile compared to ZCAR. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check ZCAR's competition here
CAI vs BRDS Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, BRDS has a market cap of 1.3M. Regarding current trading prices, CAI is priced at $36.99, while BRDS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas BRDS's P/E ratio is -0.01. In terms of profitability, CAI's ROE is +0.04%, compared to BRDS's ROE of -2.07%. Regarding short-term risk, CAI is less volatile compared to BRDS. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check BRDS's competition here
CAI vs HYRE Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, HYRE has a market cap of 486.8K. Regarding current trading prices, CAI is priced at $36.99, while HYRE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas HYRE's P/E ratio is -0.02. In terms of profitability, CAI's ROE is +0.04%, compared to HYRE's ROE of -46.89%. Regarding short-term risk, CAI is more volatile compared to HYRE. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HYRE's competition here
CAI vs ZCARW Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, ZCARW has a market cap of 3.7K. Regarding current trading prices, CAI is priced at $36.99, while ZCARW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas ZCARW's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to ZCARW's ROE of +105.44%. Regarding short-term risk, CAI is more volatile compared to ZCARW. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check ZCARW's competition here
CAI vs FTAI-PB Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAI-PB has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while FTAI-PB trades at $24.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAI-PB's P/E ratio is -12.26. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PB's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAI-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PB's competition here
CAI vs UHALB Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, UHALB has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while UHALB trades at $53.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas UHALB's P/E ratio is 9.86. In terms of profitability, CAI's ROE is +0.04%, compared to UHALB's ROE of +0.04%. Regarding short-term risk, CAI is more volatile compared to UHALB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check UHALB's competition here
CAI vs GFNCP Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, GFNCP has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while GFNCP trades at $101.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas GFNCP's P/E ratio is 146.89. In terms of profitability, CAI's ROE is +0.04%, compared to GFNCP's ROE of +0.05%. Regarding short-term risk, CAI is more volatile compared to GFNCP. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check GFNCP's competition here
CAI vs FTAI-PA Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAI-PA has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while FTAI-PA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAI-PA's P/E ratio is -12.53. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PA's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAI-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PA's competition here
CAI vs ACY Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, ACY has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while ACY trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas ACY's P/E ratio is 4.30. In terms of profitability, CAI's ROE is +0.04%, compared to ACY's ROE of +0.00%. Regarding short-term risk, CAI is less volatile compared to ACY. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check ACY's competition here
CAI vs FTAI-PC Comparison August 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 10.3B. In comparison, FTAI-PC has a market cap of 0. Regarding current trading prices, CAI is priced at $36.99, while FTAI-PC trades at $25.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -9.24, whereas FTAI-PC's P/E ratio is -13.00. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PC's ROE of +4.48%. Regarding short-term risk, CAI is more volatile compared to FTAI-PC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PC's competition here